250,000 Shares in Clarivate PLC $CLVT Purchased by Murchinson Ltd.

Key Points

• Murchinson Ltd. has acquired a new stake in Clarivate PLC, purchasing 250,000 shares valued at approximately $982,000 in the first quarter.
• Clarivate has faced significant insider selling, with insider James Gordon Samson selling 100,000 shares for $453,000, reducing his position by 7.29%.
• Several analysts have downgraded Clarivate's stock rating to "hold", with a consensus target price of $4.83 amid underperformance in revenue compared to the previous year.

Murchinson Ltd. acquired a new stake in Clarivate PLC (NYSE:CLVT - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 250,000 shares of the company's stock, valued at approximately $982,000.

Several other institutional investors and hedge funds also recently made changes to their positions in CLVT. Clarkston Capital Partners LLC increased its position in Clarivate by 5.4% during the 1st quarter. Clarkston Capital Partners LLC now owns 74,527,914 shares of the company's stock valued at $292,895,000 after purchasing an additional 3,794,083 shares during the period. HG Vora Capital Management LLC acquired a new stake in Clarivate during the 1st quarter valued at approximately $47,160,000. AustralianSuper Pty Ltd acquired a new stake in Clarivate during the 1st quarter valued at approximately $39,593,000. Vanguard Group Inc. increased its position in Clarivate by 2.5% during the 1st quarter. Vanguard Group Inc. now owns 8,969,796 shares of the company's stock valued at $35,251,000 after purchasing an additional 218,938 shares during the period. Finally, Invenomic Capital Management LP boosted its holdings in shares of Clarivate by 28.8% during the 1st quarter. Invenomic Capital Management LP now owns 8,480,296 shares of the company's stock worth $33,328,000 after buying an additional 1,894,589 shares in the last quarter. Institutional investors and hedge funds own 85.72% of the company's stock.

Insiders Place Their Bets

In related news, insider James Gordon Samson sold 100,000 shares of Clarivate stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $4.53, for a total value of $453,000.00. Following the completion of the sale, the insider owned 1,271,103 shares of the company's stock, valued at approximately $5,758,096.59. This trade represents a 7.29% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 23.18% of the company's stock.

Analyst Upgrades and Downgrades

CLVT has been the topic of a number of research analyst reports. Wolfe Research initiated coverage on Clarivate in a report on Wednesday, September 3rd. They set a "peer perform" rating on the stock. Jefferies Financial Group initiated coverage on Clarivate in a report on Friday, July 18th. They set a "hold" rating and a $4.50 price target on the stock. Finally, Wall Street Zen cut Clarivate from a "buy" rating to a "hold" rating in a report on Saturday, June 21st. Four investment analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Reduce" and an average price target of $4.83.

Clarivate Stock Up 2.0%

NYSE CLVT traded up $0.09 on Thursday, reaching $4.33. The company had a trading volume of 1,843,689 shares, compared to its average volume of 5,467,884. The stock has a market capitalization of $2.91 billion, a P/E ratio of -6.98 and a beta of 1.40. The company's fifty day moving average is $4.25 and its 200 day moving average is $4.13. Clarivate PLC has a 52-week low of $3.04 and a 52-week high of $7.15. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.90.

Clarivate (NYSE:CLVT - Get Free Report) last announced its earnings results on Wednesday, July 30th. The company reported $0.18 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.18. Clarivate had a positive return on equity of 8.65% and a negative net margin of 17.33%.The firm had revenue of $621.40 million during the quarter, compared to analyst estimates of $587.17 million. During the same period last year, the firm posted $0.20 EPS. The business's revenue was down 4.4% compared to the same quarter last year. Clarivate has set its FY 2025 guidance at 0.600-0.700 EPS. Sell-side analysts anticipate that Clarivate PLC will post 0.63 earnings per share for the current fiscal year.

About Clarivate

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.